FTY720 in corneal concordant xenotransplantation

Transplantation

Volumn 79, Issue 3, 2005, Pages 297-303

  Sedláková, Klára ^a,b,c   Muckersie, Elizabeth ^a   Robertson, Marie ^a   Filipec, Martin ^b,c   Forrester, John V ^a,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cornea; Epithelium; FTY720; Mouse; Rat; Xenotransplantation

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; FINGOLIMOD; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CORNEA ULCER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EPITHELIUM CELL; EVALUATION; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHATIC DRAINAGE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; CORNEAL TRANSPLANTATION; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; MICE; MICE, INBRED BALB C; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOSINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 14544277656     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000151005.37985.DE     Document Type: Article

References (50)

1. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 1992; 110: 1392.
2. Williams KA, Roder D, Esterman A, et al. Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. Ophthalmology 1992; 99: 403.
3. Reinhard T, Bohringer D, Enczmann J, et al. HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol 2003; 36: 42.
4. Khaireddin R, Wachtlin J, Hopfenmuller W, Hoffmann F. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection. Graefes Arch Clin Exp Ophthalmol 2003; 241: 1020.
5. Qian Y, Dana MR. Molecular mechanisms of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med 2001; 2001: 1.
6. Yamagami S, Isobe M, Yamagami H, et al. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. Transplantation 1997; 64: 42.
7. Tanaka K, Yamada J, Streilein JW. Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice. Invest Ophthalmol Vis Sci 2000; 41: 1827.
8. Chitilian HV, Laufer TM, Stenger K, et al. The strength of cell-mediated xenograft rejection in the mouse is due to the CD4+ indirect response. Xenotransplantation 1998; 5: 93.
9. Higuchi R, Streilein JW. CD8+ T Cell-Mediated Delayed Rejection of Orthotopic Guinea Pig Cornea Grafts in Mice Deficient in CD4+ T Cells. Invest Ophthalmol Vis Sci 2003; 44: 175.
10. Larkin DF, Takano T, Standfield SD, Williams KA. Experimental orthotopic corneal xenotransplantation in the rat. Mechanisms of graft rejection. Transplantation 1995; 60: 491.
11. Ross JR, Sanfilippo FP, Howell DN. Histopathologic features of rejecting orthotopic corneal xenografts. Curr Eye Res 1994; 13: 725.
12. Hegde S, Mellon JK, Hargrave SL, Niederkorn JY. Effect of Alloantibodies on Corneal Allograft Survival. Invest Ophthalmol Vis Sci 2002; 43: 1012.
13. Goslings WR, Yamada J, Dana MR, et al. Corneal transplantation in antibody-deficient hosts. Invest Ophthalmol Vis Sci 1999; 40: 250.
14. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 2004; 15: 513.
15. Paugh SW, Payne SG, Barbour SE, et al. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett 2003; 554: 189.
16. Billich A, Bornancin F, Devay P, et al. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 2003; 278: 47408.
17. Sanchez T, Estrada-Hernandez T, Paik JH, et al. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 2003; 278: 47281.
18. Allende ML, Sasaki T, Kawai H, et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004 Sep 30; [Epub ahead of print].
19. Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277: 21453.
20. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002; 296: 346.
21. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 427: 355.
22. Allende ML, Dreier JL, Mandala S, Proia RL. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 2004; 279: 15396.
23. Graler MH, Goetzl EJ. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J 2004; 18: 551.
24. Suzuki S, Enosawa S, Kakefuda T, et al. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats. Transpl Immunol 1996; 4: 252.
25. Suzuki S, Kakefuda T, Amemiya H, et al. An immunosuppressive regimen using FTY720 combined with cyclosporin in canine kidney transplantation. Transpl Int 1998; 11: 95.
26. Suzuki S, Enosawa S, Kakefuda T, et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61: 200.
27. Masubuchi Y, Kawaguchi T, Ohtsuki M, et al. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. Transplant Proc 1996; 28: 1064.
28. Xu M, Antoniou EA, Afford SC, et al. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation. Transplant Proc 1997; 29: 2964.
29. Zhang EP, Muller A, Ignatius R, Hoffmann F. Significant prolongation of orthotopic corneal-graft survival in FTY720-treated mice. Transplantation 2003; 76: 1511.
30. Suzuki K, Yan H, Li XK, et al. Prevention of experimentally induced autoimmune type I diabetes in rats by the new immunosuppressive reagent FTY720. Transplant Proc 1998; 30: 1044.
31. Mitsusada M, Suzuki S, Kobayashi E, et al. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Transpl Int 1997; 10: 343.
32. Miyata Y, Ohdan H, Noriyuki T, et al. Prolongation of concordant xenograft survival by treatment with FTY720. Transplant Proc 1998; 30: 4163.
33. Maeda A, Goto M, Zhang J, et al. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats. Transplantation 2003; 75: 1409.
34. Fujiwara I, Nakajima H, Matsuda T, et al. Prolongation of concordant xenograft survival by a newly developed drug, FTY720. Transplant Proc 1999; 31: 2831.
35. Fukuda Y, Ohdan H, Miyata Y, et al. Effect of FTY720 on immunoregulation in concordant xenotransplantation. Transpl Int 1998; 11: S461.
36. Yagi H, Kamba R, Chiba K, et al. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur J Immunol 2000; 30: 1435.
37. Yanagawa Y, Sugahara K, Kataoka H, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998; 160: 5493.
38. Ueda H, Takahara S, Azuma H, et al. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats. Eur Surg Res 2000; 32: 279.
39. Hozumi Y, Kobayashi E, Miyata M, Fujimura A. Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720. Life Sci 1999; 65: 1739.
40. Miyamoto T, Matsumori A, Hwang MW, et al. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. J Am Coll Cardiol 2001; 37: 1713.
41. Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160: 5037.
42. Luo ZJ, Tanaka T, Kimura F, Miyasaka M. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology 1999; 41: 199.
43. Zhang J, Song Z, Wijkstrom M, et al. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model. Transplant Proc 2000; 32: 1017.
44. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg 1990; 21: 781.
45. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 2001; 42: 1293.
46. Plskova J, Duncan L, Holan V, et al. The immune response to corneal allograft requires a site-specific draining lymph node. Transplantation 2002; 73: 210.
47. Hori J, Streilein JW. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001; 42: 1820.
48. Konishi K, Inobe M, Yamada A, et al. Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model. J Heart Lung Transplant 2002; 21: 692.
49. Kurose S, Ikeda E, Tokiwa M, et al. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Exp Eye Res 2000; 70: 7.
50. Hwang MW, Matsumori A, Furukawa Y, et al. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 1999; 100: 1322.